Skip to content
stoqly

Olin

OLN NYSE Diversified Chemicals Financials FY2016–FY2025

Olin's revenue rose 3.7% to $6.8 billion in fiscal 2025. Its operating margin was 0.1%, down from 4.5% a year earlier. Free cash flow was $248 million, down 19.5%. It paid out $142 million in dividends and buybacks, 57% of free cash flow. The diluted share count fell 4.1%.

Last close Β· Oct 23, 2026

$15.66

0.8%
Revenue Total sales reported in the income statement.
$6.8B
3.7% vs prior year
Operating margin Operating income as a share of revenue.
0.1%
4.5 pts
Net income Profit after all expenses, interest and tax.
βˆ’$101M
196.3%
Free cash flow Cash from operations minus capital spending.
$248M
19.5%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
0.1%
4.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$1.8B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”

What Olin does

No business description yet.

Legal name
OLIN CORPORATION
Fiscal year ends
December 31, 2025
Latest annual report
β€”
Accession Β· CIK
0000074303-26-000027
0000074303

Revenue and margins

Olin had $6.8B of revenue in fiscal 2025, up 3.7% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $248M in fiscal 2025, 3.7% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Olin returned $142M to shareholders in fiscal 2025, 57% of free cash flow. The diluted share count fell 4.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Olin yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$2.7B and divides by 114.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Balance sheet

Cash, debt and the ratios that show how comfortably Olin can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $181M$194M$170M$176M$168M
Debt incl. finance leases $2.8B$2.6B$2.7B$2.9B$2.8B
Net debt / EBITDA 1.1x1.0x2.0x3.3x5.1x
Debt / equity 1.1x1.0x1.2x1.4x1.6x
Interest coverage 5.3x12.4x3.9x1.6x0.0x
Current ratio 1.3x1.4x1.3x1.3x1.2x
Quick ratio 0.8x0.8x0.7x0.8x0.7x
Total assets $8.5B$8.0B$7.7B$7.6B$7.3B
Total liabilities $5.9B$5.5B$5.4B$5.5B$5.5B
Shareholders' equity $2.7B$2.5B$2.2B$2.0B$1.8B
Net debt (βˆ’ = net cash) $2.6B$2.4B$2.5B$2.7B$2.7B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$2.5M

5 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Feb 25, 2026 Deon CarterVP & President CAPV Sold 6,500 $23.73 $0.2M Form 4
Feb 24, 2026 Angela M CastleVP & Chief Legal Officer Sold 2,379 $24.25 $0.1M Form 4
Feb 3, 2026 Sumner R NicholeVP & Controller Sold 4,750 $22.49 $0.1M Form 4
Feb 3, 2026 Todd A SlaterVP & CFO Sold 92,250 $22.48 $2.1M Form 4
Nov 26, 2025 Teresa M VermillionVP & Treasurer Sold 4,500 $20.86 $0.1M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ•
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ• βœ• βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ• βœ• βœ•
Current ratio rose βœ• βœ• βœ•
Share count didn't rise βœ“ βœ“ βœ“
Gross margin rose βœ• βœ• βœ•
Revenue rose relative to assets βœ• βœ• βœ“
F-score 4 / 94 / 94 / 9
Accruals ratio βˆ’6.6%βˆ’5.2%βˆ’7.7%
Altman Z'' 2.532.061.62

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Olin OLN $1.8B 3.7% 0.1% 3.7% 0.1% β€” 4
Chemours CC $1.9B 0.5% β€” 0.9% βˆ’0.2% β€” 4 Compare β†’
Cabot CBT $3.9B βˆ’7.0% 16.7% 10.5% 15.9% 12.9x 6 Compare β†’
Ashland Global ASH $3.4B βˆ’13.7% βˆ’42.5% 2.0% βˆ’17.5% 69.5x 5 Compare β†’
CF Industries CF $18.6B 19.3% 32.5% 25.4% 20.6% 9.0x 8 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $5.6B $6.3B $6.9B $6.1B $5.8B $8.9B $9.4B $6.8B $6.5B $6.8B
Gross profit $606M $714M $1.1B $671M $383M $2.3B $2.2B $1.2B $738M $502M
Operating income $108M $297M $677M $178M βˆ’$747M $1.9B $1.8B $712M $297M $5.3M
Interest expense $192M $217M $243M $243M $293M $348M $144M $181M $185M $188M
Pretax income βˆ’$34.2M $117M $437M βˆ’$36.9M βˆ’$1.0B $1.5B $1.7B $559M $142M βˆ’$161M
Income tax βˆ’$30.3M βˆ’$432M $109M βˆ’$25.6M βˆ’$50.1M $242M $349M $107M $36.7M βˆ’$60.0M
Net income βˆ’$3.9M $550M $328M βˆ’$11.3M βˆ’$970M $1.3B $1.3B $452M $105M βˆ’$101M
Diluted EPS βˆ’$0.02 $3.26 $1.95 βˆ’$0.07 βˆ’$6.14 $7.96 $8.94 $3.57 $0.91 βˆ’$0.88
Diluted shares 0.17B 0.17B 0.17B 0.16B 0.16B 0.16B 0.15B 0.13B 0.12B 0.11B
Cash flow
Cash from operations $603M $649M $908M $617M $433M $1.7B $1.9B $974M $503M $474M
Capital expenditure $278M $294M $385M $386M $299M $201M $237M $236M $195M $226M
Free cash flow $325M $355M $523M $232M $134M $1.5B $1.7B $738M $308M $248M
Depreciation and amortization $534M $559M $601M $597M $568M $583M $599M $533M $518M $522M
Stock-based compensation $7.5M $9.1M $12.0M $10.7M $13.6M $8.3M $14.1M $18.6M $17.1M $20.7M
Acquisitions $69.5M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $63.9M $0.0M $55.8M
Share buybacks $0.0M $0.0M $50.0M $146M $0.0M $252M $1.4B $711M $300M $50.5M
Dividends paid $132M $133M $134M $129M $126M $128M $116M $101M $94.2M $91.6M
Dividends and buybacks $132M $133M $184M $275M $126M $380M $1.5B $812M $395M $142M
Balance sheet
Cash and short-term investments $185M $218M $179M $221M $190M $181M $194M $170M $176M $168M
Total debt $3.6B $3.6B $3.2B $3.3B $3.9B $2.8B $2.6B $2.7B $2.9B $2.8B
Finance lease liabilities $0.0M $0.0M $0.0M $5.3M $4.3M $3.0M $1.9M $0.0M $0.0M $0.0M
Current assets $1.5B $1.7B $1.7B $1.7B $1.7B $2.2B $2.2B $2.0B $2.1B $2.0B
Current liabilities $923M $954M $1.1B $1.1B $1.2B $1.7B $1.6B $1.5B $1.6B $1.6B
Inventory $630M $683M $711M $696M $675M $868M $942M $859M $824M $785M
Property and equipment, net $3.7B $3.6B $3.5B $3.3B $3.2B $2.9B $2.7B $2.5B $2.3B $2.2B
Total assets $8.8B $9.2B $9.0B $9.2B $8.3B $8.5B $8.0B $7.7B $7.6B $7.3B
Total liabilities $6.5B $6.5B $6.2B $6.8B $6.8B $5.9B $5.5B $5.4B $5.5B $5.5B
Shareholders' equity $2.3B $2.8B $2.8B $2.4B $1.5B $2.7B $2.5B $2.2B $2.0B $1.8B
Margins
Gross margin 10.9% 11.4% 16.2% 11.0% 6.7% 25.8% 23.3% 17.1% 11.3% 7.4%
Operating margin 1.9% 4.7% 9.8% 2.9% βˆ’13.0% 20.8% 19.0% 10.4% 4.5% 0.1%
EBITDA margin 11.6% 13.7% 18.4% 12.7% βˆ’3.1% 27.3% 25.4% 18.2% 12.5% 7.8%
Net margin βˆ’0.1% 8.8% 4.7% βˆ’0.2% βˆ’16.8% 14.6% 14.2% 6.6% 1.6% βˆ’1.5%
FCF margin 5.9% 5.7% 7.5% 3.8% 2.3% 17.3% 18.0% 10.8% 4.7% 3.7%
Returns
Return on capital 1.5% 5.0% 8.4% 2.5% βˆ’11.1% 30.0% 27.7% 11.8% 4.6% 0.1%
Return on capital employed 1.4% 3.7% 8.4% 2.2% βˆ’9.8% 26.6% 26.7% 11.2% 4.9% 0.1%
Return on equity βˆ’0.2% 21.9% 11.7% βˆ’0.4% βˆ’50.2% 63.2% 51.1% 18.9% 4.9% βˆ’5.2%
Return on assets βˆ’0.0% 6.1% 3.6% βˆ’0.1% βˆ’11.1% 15.5% 16.0% 5.7% 1.4% βˆ’1.4%
Growth
Revenue growth 94.5% 12.9% 10.8% βˆ’12.0% βˆ’5.8% 54.8% 5.2% βˆ’27.1% βˆ’4.3% 3.7%
Net income growth β€” β€” βˆ’40.3% βˆ’103.5% β€” β€” 2.3% βˆ’65.9% βˆ’76.8% βˆ’196.3%
EPS growth β€” β€” βˆ’40.2% βˆ’103.6% β€” β€” 12.3% βˆ’60.1% βˆ’74.5% βˆ’196.7%
FCF growth 277.3% 9.0% 47.4% βˆ’55.7% βˆ’42.1% 1,048.7% 9.4% βˆ’56.2% βˆ’58.3% βˆ’19.5%
Share count change 59.8% 2.0% βˆ’0.1% βˆ’3.6% βˆ’2.7% 3.2% βˆ’8.9% βˆ’13.3% βˆ’7.2% βˆ’4.1%
Financial health
Net debt / EBITDA 5.4x 4.0x 2.4x 4.0x β€” 1.1x 1.0x 2.0x 3.3x 5.1x
Debt / equity 1.6x 1.3x 1.1x 1.4x 2.7x 1.1x 1.0x 1.2x 1.4x 1.6x
Interest coverage 0.6x 1.4x 2.8x 0.7x βˆ’2.6x 5.3x 12.4x 3.9x 1.6x 0.0x
Current ratio 1.7x 1.8x 1.5x 1.6x 1.4x 1.3x 1.4x 1.3x 1.3x 1.2x
Quick ratio 1.0x 1.1x 0.9x 0.9x 0.9x 0.8x 0.8x 0.7x 0.8x 0.7x
Capital allocation
Capex / revenue 5.0% 4.7% 5.6% 6.3% 5.2% 2.3% 2.5% 3.5% 3.0% 3.3%
Stock comp / revenue 0.1% 0.2% 0.2% 0.2% 0.2% 0.1% 0.2% 0.3% 0.3% 0.3%
Payouts / FCF 40.6% 37.5% 35.1% 118.8% 94.2% 24.7% 87.1% 110.0% 128.0% 57.3%
Quality scores
Piotroski F-score 4.0 7.0 7.0 4.0 3.0 7.0 7.0 4.0 4.0 4.0
Altman Z'' 1.1 1.5 1.8 1.3 βˆ’0.0 2.8 3.4 2.5 2.1 1.6
Accruals ratio βˆ’6.7% βˆ’1.1% βˆ’6.4% βˆ’6.9% βˆ’16.1% βˆ’5.3% βˆ’7.2% βˆ’6.6% βˆ’5.2% βˆ’7.7%

Source: SEC EDGAR XBRL filings (CIK 0000074303). Data updated October 13, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open